SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr.Reddy's Laboratories informs about outcome of board meeting

30 Jan 2024 Evaluate
Dr.Reddy's Laboratories has informed that the Board of Directors of the Company, at its meeting held on January 30, 2024, has approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023. In terms of the above, it also enclosed the following: Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2023, prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB); Press Release on Financial Results of the Company for the above period; Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2023, as per Indian Accounting Standards; Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2023, as per Indian Accounting Standards. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Limited Review Reports of the Statutory Auditors on the Unaudited Standalone and Consolidated Financial Results as mentioned at serial nos. 3 and 4 are also enclosed. The Board Meeting commenced at 11.54 am IST and concluded at 3.45 pm IST.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1291.05 19.50 (1.53%)
22-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.45
Dr. Reddys Lab 1291.05
Cipla 1415.30
Zydus Lifesciences 1084.35
Lupin 2339.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: